Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

TERMINATED

Understanding Hemophilia A and B Drug Dosage Administration Patterns

Lead Sponsor:

Pfizer

Conditions:

Hemophilia A

Hemophilia B

Eligibility:

All Genders

Brief Summary

Study Design A prospective observational, cross-sectional epidemiological study in U.S. site-based clinical practice settings. 30 sites will enroll approximately 300 patients Participating patients...

Detailed Description

Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. Subjects currently enrolled into the study have completed the study as per protocol. The...

Eligibility Criteria

Inclusion

  • Physician/Clinician Participants:
  • Must be a healthcare provider
  • Currently manages at least 10 hemophilia A and/or B patients
  • Patient Participants:
  • Willing and able to provide informed consent
  • Diagnosed with hemophilia A or B
  • Current disease severity is either moderately severe or severe with a clotting factor level of ≤5%
  • If suffering from hemophilia A, must be currently taking moroctocog alfa (or another standard half-life treatment), rurioctocog alfa or efraloctocog alfa for at least six months.
  • (If currently taking rurioctocog alfa or efraloctocog alfa, must have been switched from a standard half-life treatment and had been on that prior treatment for at least six months).
  • If suffering from hemophilia B, must be currently taking nonacog alfa or eftrenonacog alfa for at least six months (If currently taking eftrenonacog alfa, must have switched from nonacog alfa and had been on that prior treatment for at least six months).
  • Infuse at least 3 times per month
  • Exclusion criteria:
  • Female with hemophilia A or B
  • Mild Haemophilia A or B

Exclusion

    Key Trial Info

    Start Date :

    September 1 2017

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 14 2018

    Estimated Enrollment :

    11 Patients enrolled

    Trial Details

    Trial ID

    NCT03248141

    Start Date

    September 1 2017

    End Date

    March 14 2018

    Last Update

    May 20 2019

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    University of Florida College of Medicine

    Gainesville, Florida, United States, 32610

    2

    Alliance for Childhood Diseases, dba Hemophilia Treatment Center of Nevada

    Las Vegas, Nevada, United States, 89109

    3

    Cook Children's Medical Center

    Fort Worth, Texas, United States, 76104